MARÍA ESTHER
MANCEBO SIERRA
Investigadora en el periodo 2012-2019
Hospital Virgen de la Arrixaca
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (9)
2024
-
Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch
Transplantation, Vol. 108, Núm. 3, pp. 787-801
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
GeroScience, Vol. 45, Núm. 1, pp. 543-553
-
Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study
Andrology, Vol. 11, Núm. 1, pp. 24-31
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19
Scientific reports, Vol. 12, Núm. 1, pp. 10369
2016
-
High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients
Immunobiology, Vol. 221, Núm. 5, pp. 595-603
-
High frequency of central memory regulatory t cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation
International Immunology, Vol. 28, Núm. 2, pp. 55-64
2015
-
Activated Regulatory T Cells Expressing CD4+CD25highCD45RO+CD62L+ Biomarkers Could Be a Risk Factor in Liver Allograft Rejection
Transplantation Proceedings, Vol. 47, Núm. 8, pp. 2380-2381